Novo Nordisk sues Hims & Hers over ‘knock-off Wegovy’

Pharmaceutical giant Novo Nordisk announced Monday it is suing telemedicine platform Hims & Hers for allegedly “deceiving patients and putting their health at risk” by selling compounded versions of its blockbuster GLP-1 medication semaglutide. Novo Nordisk alleges in its lawsuit that Hims & Hers has infringed on its patent by selling compounded Ozempic and Wegovy…

Novo Nordisk sues Hims & Hers over ‘knock-off Wegovy’

EPA set to repeal landmark finding that climate change endangers the public

FDA reviewing food preservative BHA

FDA reviewing food preservative BHA

How to untangle ethics of psychedelics for therapeutic care

Novel therapy reduces depression in family caregivers

Planned Parenthood to spend $40m to boost Biden, Democrats ahead of November

2 years in, 988 has answered 10 million calls, texts and chats

Biden administration suspends funding for scientist at center of COVID lab leak theory

Novel teamwork, promising results for glioblastoma treatment

‘Harvard Thinking’: Facing death with dignity

Asking the internet about birth control

FDA reviewing food preservative BHA

Novo Nordisk sues Hims & Hers over ‘knock-off Wegovy’

EPA set to repeal landmark finding that climate change endangers the public

Two men charged in $120M adult day care fraud scheme in Queens

Recent News

FDA reviewing food preservative BHA

Novo Nordisk sues Hims & Hers over ‘knock-off Wegovy’

EPA set to repeal landmark finding that climate change endangers the public

Two men charged in $120M adult day care fraud scheme in Queens

Recent News

FDA reviewing food preservative BHA

Novo Nordisk sues Hims & Hers over ‘knock-off Wegovy’

Popular News

About Health Land Corporation